- FLOMAXTRA is used in men who have symptoms associated with Benign Prostatic Hyperplasia (also know as BPH). In BPH the prostate gland is bigger than normal and affects how well men can pass urine.
- BPH is a common male condition. With increasing age, the prostate enlarges putting pressure on the urethra thus affecting urination. Common symptoms include frequency of urination, an urgent desire to urinate, weak stream, dribbling after urinating, and the feeling of incomplete bladder emptying or waking in the night to urinate (nocturia). For more information on BPH click here.
- FLOMAXTRA treats the symptoms above by relaxing the smooth muscle of the prostate and urethra to improve urination and your quality of life. FLOMAXTRA tablets also have the added benefit of an advanced controlled release system, meaning more consistent control of symptoms 24 hours per day.
FLOMAXTRA - tamsulosin hydrochloride tablets 0.4mg
Do not use FLOMAXTRA if you are allergic to any of its components, if you have serious liver or kidney problems, or if you have orthostatic hypotension (dizziness when standing due to a fall in blood pressure).
Tell your doctor if you have any allergies, or if you are taking any other medicine as these may affect how FLOMAXTRA works.
FLOMAXTRA can cause some side effects. Side effects not listed here may occur in some patients. FLOMAXTRA may cause side effects such as abnormal ejaculation, dizziness (or dizziness on standing), headache, weakness, heart palpitations, allergic reaction.
FLOMAXTRA is a non-funded prescription medicine. You will need to pay for this medicine. Normal doctors fees and Pharmacy charges apply.
As with all medicines FLOMAXTRA has risks and benefits. Speak to your doctor to see if FLOMAXTRA is right for you.
Note: Information on this site is not intended to replace the advice given by your doctor or other health professional.
For further information, click on the helpful links below.
TAPS no: PP3212.
everybody.co.nz – BPH
Consumer Medicine Information
Medicine Data Sheet
Last Updated: 16-09-2013